Now Reading:
Octave Bioscience Announces New CEO, Board Chairman
Full Article 40 second read

Octave Bioscience Announces New CEO, Board Chairman

By Healthcare Edge Editorial Staff

Octave Bioscience, Inc. said Founder William Hagstrom will become Chairman of the Board, while Doug Biehn is the new President and CEO.

Mr. Biehn has over 20 years of experience in healthcare, building and scaling growth businesses, the company, which treats neurodegenerative diseases, wrote in a statement.

Before joining Octave, Mr. Biehn held executive leadership roles at iRhythm Technologies, McKesson, AliveCor, Blue Shield of California and Cala Health, it said.

“It’s a privilege to build upon the foundation of innovative science and technology that Bill and the team have created and lead the company through its next phase of growth,” said Mr. Biehn.


Healthcare Edge

Leave a Reply

Your email address will not be published. Required fields are marked *

Input your search keywords and press Enter.